MYOS RENS Technology, Inc.
(NASDAQ : MYOS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.36%480.271.0%$539.93m
ABTAbbott Laboratories -1.53%107.810.8%$513.96m
DHRDanaher Corp. -0.52%232.770.7%$492.46m
MDTMedtronic Plc -0.38%111.420.6%$454.97m
ALGNAlign Technology, Inc. 3.60%469.566.4%$392.73m
ISRGIntuitive Surgical, Inc. 0.35%735.482.3%$390.03m
BSXBoston Scientific Corp. 0.81%37.161.0%$330.07m
DXCMDexCom, Inc. 3.84%411.007.9%$310.21m
BDXBecton, Dickinson & Co. -0.29%240.401.0%$273.84m
QDELQuidel Corp. 1.01%248.217.7%$218.44m
BAXBaxter International, Inc. -0.43%81.101.8%$204.00m
SYKStryker Corp. -1.15%222.061.3%$202.55m
VARVarian Medical Systems, Inc. 0.48%172.569.1%$189.77m
EWEdwards Lifesciences Corp. 1.30%80.410.4%$183.32m
IDXXIDEXX Laboratories, Inc. 1.43%429.663.8%$138.89m

Company Profile

MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.